| Dr Gregory Glenn Schwartz, MD PHD | |
|
1700 Wheeling St # 111b, Aurora, CO 80045-7211 | |
| (720) 723-6061 | |
| Not Available |
| Full Name | Dr Gregory Glenn Schwartz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1700 Wheeling St # 111b, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275508467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | G57827 (California) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 37922 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Glenn Schwartz, MD PHD 1055 Clermont St, Cardiology 111b, Denver Va Medical Center, Denver, CO 80220-3808 Ph: (303) 393-2826 | Dr Gregory Glenn Schwartz, MD PHD 1700 Wheeling St # 111b, Aurora, CO 80045-7211 Ph: (720) 723-6061 |
News Archive
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced the initiation of a Phase 2a clinical trial to evaluate the gastrointestinal (GI) antibiotic-degrading effects and the safety of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent C. difficile infection (CDI).
PENTAX Medical sets a new standard in endoscopic ultrasound with the official launch of the EG-3270UK endoscope during the 30th GEEW congress in Brussels, Belgium.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
Geneva, Switzerland: Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumour is kept to the minimum.
› Verified 5 days ago
Samiran Bhattacharya, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1635 Aurora Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Payal Rohit Patel, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-6024 | |
Jonathan A Gutman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Jeffrey Glasheen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Micol Rothman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Larry Allen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Virginia Borges, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |